abstract |
The present invention concerns aza- and diazacycloheptane and cyclooctane compounds from the following formula (I) Ar<1>-A-B-Ar<2> wherein Ar<1>, A, B, and Ar<2> have the meanings given in the description. The compounds according to the invention possess a high affinity with the dopamine-D3-receptors and can therefore be used for the treatment of illness, which react to dopamine-D3-ligands. |